Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

This Investor Thinks Microsoft Corporation (MSFT) Can Do Better Than Buying, inc. (CRM)

Microsoft Corporation (NASDAQ:MSFT) may be acquiring a company that is vulnerable to disruption by newer companies with fresher technologies if it were to acquire, inc. (NYSE:CRM).

That’s according to Roger McNamee in an interview with CNBC where he explained why he thinks Microsoft Corporation (NASDAQ:MSFT) should not buy, inc. (NYSE:CRM).

According to the Elevation Partners co-founder, he would send a letter to the Board of Directors begging them to not proceed with the acquisition of, inc. (NYSE:CRM) if he were a Microsoft Corporation (NASDAQ:MSFT) shareholder.

McNamee points out that large transactions in the software industry have historically been disastrous in the aftermath.

“If I’m Microsoft, they shouldn’t be waiting until companies are the scale of Salesforce to acquire them. They should be building things internally. They have a lot of opportunities to do that,” McNamee tells CNBC, adding, “In fact, I think we are coming up to the time where Salesforce will be vulnerable to new technology. I do think that this is one of those things that this is fun to talk about – and if I were [Marc] Benioff [Salesforce CEO] I would hit the bid in a heartbeat if somebody offered $50 billion plus – but I think from Microsoft’s point of view, it would be strategically a terrible mistake.”

Microsoft Corporation (NASDAQ:MSFT) has recently been reported to be studying a bid for, inc. (NYSE:CRM) in a deal that would be worth upwards of $50 billion or even well into the $70 billion range.

Other industry observers like Dan Ives of FBR Capital Markets think the deal would be great for the Window’s maker. Not McNamee, however.

“If I’m Microsoft, what I want from Salesforce is less the product than sort of the joie de vivre that comes with a company run by Marc Benioff. I don’t think Microsoft is shopping for a new CEO. As a consequence, I think the one thing they are certain not to get if they were to acquire Salesforce would be the culture. I think, in fact, a large number of people would leave right away. They would have the products and the products would be of some value, but I don’t think you can justify $50 billion or more to acquire a company at that stage,” he tells CNBC.

Microsoft, is MSFT a good stock to buy, NASDAQ:MSFT, is CRM a good stock to buy, Salesforce, NYSE:CRM, Roger McNamee, Elevation Partners

Jean-Marie Eveillard’s First Eagle Investment Management owned about 36.23 million shares of Microsoft Corporation (NASDAQ:MSFT) by the end of 2014. Also by the end of last year, Christopher Lord’s Criterion Capital owned about 2 million, inc. (NYSE:CRM) shares.

I just made 84% in 4 daysI Just Made 84% in 4 Days By Blindly Following This Hedge Fund

I just made 84% in 4 days by blindly imitating a hedge fund’s stock pick. I will tell you how I pulled such a huge return in such a short time but let me first explain in this FREE REPORT why following hedge funds’ stock picks is one of the smartest things you can do as an investor. We launched our quarterly newsletter 2.5 years ago and not one subscriber has, since, said ‘I lost money by EXACTLY following your stock picks’. The reason is simple. You can beat index funds by creating a DREAM TEAM of hedge fund managers and investing in only their best ideas. I just made 84% in 4 days by blindly imitating one of these best ideas. CLICK HERE NOW for all the details.

Suggested Articles:

Most Profitable Companies

Most Profitable Franchises

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!